Our news

1678 news items

Research

TOPAZ trial of apitegromab in SMA

On 29/03/2024

The TOPAZ trial tested the safety, tolerability and efficacy of the anti-myostatin apitegromab in SMA over one year in the United States and Europe (but…

Research

News of enzyme therapy in Pompe disease

On 27/03/2024

Several laboratories are developing recombinant enzymes for the treatment of Pompe disease: Sanofi-Genzyme, already the originator of the first marketed treatment, Myozyme, has developed a…